Dedicare AB (FRA:CL6) YoY EBITDA Growth: 36.36% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CL6 Dedicare AB FRA:CL6
76 GF Score
Price €5.04
GF Value €4.07
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Dedicare AB YoY EBITDA Growth?

Dedicare AB FRA:CL6 -0.98% 76 YoY EBITDA Growth is 36.36% as of Jun. 2026. GuruFocus rates FRA:CL6 with a GF Score™ of 76/100 and a GF Value™ of €4.07 (Modestly Overvalued). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dedicare AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 36.36%.

Dedicare AB's EBITDA per Share for the three months ended in Jun. 2026 was €0.21.

Dedicare AB YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Dedicare AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dedicare AB YoY EBITDA Growth Chart

Dedicare AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.58 38.49 8.17 -49.12 -20.17

Dedicare AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.63 8.00 -27.57 -7.03 36.36
FRA:CL6
76GF Score
Dedicare AB FRA:CL6
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dedicare AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dedicare AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.645-0.808)/ | 0.808 |
=-20.17 %

Dedicare AB's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.21-0.154)/ | 0.154 |
=36.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 36.36% mean?
Dedicare AB (FRA:CL6) has a YoY EBITDA Growth of 36.36% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dedicare AB and its competitors.
Is Dedicare AB's YoY EBITDA Growth too high?
Dedicare AB's current YoY EBITDA Growth is 36.36%. Overall, Dedicare AB has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dedicare AB's YoY EBITDA Growth compare to RHI and KFY?
Dedicare AB's YoY EBITDA Growth of 36.36% can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Business Services company?
A good YoY EBITDA Growth depends on the Business Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dedicare AB and its competitors. Dedicare AB's current YoY EBITDA Growth is 36.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dedicare AB stock overvalued right now?
Based on GuruFocus' analysis, Dedicare AB (FRA:CL6) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.07, compared to a current price of €5.04 — trading 23.8% above its estimated fair value. The current YoY EBITDA Growth is 36.36%. Dedicare AB's overall GF Score™ is 76/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Dedicare AB (FRA:CL6), the current YoY EBITDA Growth is 36.36% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dedicare AB (FRA:CL6) Overvalued in 2026?

Based on GuruFocus' analysis, Dedicare AB stock appears to be overvalued. The current stock price of €5.04 is trading 23.8% above its estimated GF Value™ of €4.07. GuruFocus considers Dedicare AB to be Modestly Overvalued.

Key valuation signals for FRA:CL6:

  • YoY EBITDA Growth: 36.36%
  • GF Value™: €4.07 vs. price of €5.04 (23.8% above fair value)
  • GF Score™: 76/100 with 9 warning signs

No single metric tells the full story. See the FRA:CL6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dedicare AB Business Description

Other Exchanges DEDI:Sweden0P3K:UK
Address Dalagatan 100, 5th Floor, Stockholm, SWE, 113 43
Dedicare AB is engaged in providing staffing and recruitment services within the healthcare and social care sectors. The company supplies qualified healthcare professionals, including doctors and nurses, as well as personnel such as social workers, psychologists, and other specialists in social care. Its geographical segments include Sweden (including Finland), Norway, Denmark, and the United Kingdom, from which it generates the majority of its revenue from Norway.
76GF Score

Get the complete analysis for FRA:CL6

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.04
Price
€4.07
GF Value